Safety and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Addiction Tony Nguyen, PGY2.

Slides:



Advertisements
Similar presentations
Jean-François ETTER Evelyne LASZLO Jean-Pierre ZELLWEGER Charles PERROT Thomas PERNEGER University of Geneva, Switzerland Smoking reduction with NRT: a.
Advertisements

STAGES OF CHANGE Precontemplation Contemplation Action Maintenance Relapse Not yet considering quitting Thinking about quitting Making a quit attempt Remaining.
A Virtual Arm to Stop Smoking A comparative study B. Girard 1, V. Turcotte 1 and S. Bouchard 2 1.GRAP, Occupational psychology clinic Saguenay (Québec)
ABCs of Behavioral Support Jonathan Foulds PhD. Penn State – College of Medicine
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
Smoking and mental health Mark Allen Specialist Health Improvement Practitioner.
Dejar de Fumar Hoy - Quit Smoking Now: A Smoking Cessation Program for Latinos Sally Haack, Pharm.D., BCPS; Naomi Barasch, Pharm.D. Candidate Drake University.
Secondhand Smoke Exposure, Smoking and Children’s Health Coordinator Name Alabama Dept. of Public Health.
Prevention strategies
Smoking Cessation. Opportunity for Physicians 70 percent of smokers want to quit. Without assistance only 5 percent are able to quit. Most try to quit.
Tobacco Chapter 8 ???? ____ % of new smokers are adolescents/teenagers ???? Smokers have about a _____% greater risk of dying from coronary heart disease.
SMOKING and TEENAGERS For questions regarding this presentation, please contact: Karen Hudmon, DrPH, MS, RPh Yale University School of Medicine Department.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2011.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
Basics: 2As & R Clinical Intervention Artwork by Nancy Z. © 2010 American Aca0emy of Pediatrics (AAP) Children's Art Contest. Support for the 2010 AAP.
1 CTRI Webinar: Combination Medication Effectiveness June 9, 2010 Stevens S. Smith, Ph.D. Megan E. Piper, Ph.D. Center for Tobacco Research & Intervention.
SMOKING CESSATION Leading Preventable Cause of Death 400,000 to 500,000 deaths per year in USA 3 Million deaths world wide 1 of every 6 deaths in USA Directly.
TREATING SPECIAL POPULATIONS. OVERVIEW Tobacco Treatment Smoking Outcomes Co-occurring Disorders Integration Tobacco Prevention.
1 Adolescent Mental Health: Key Data Indicators Gwendolyn J. Adam, Ph.D., L.C.S.W. Assistant Professor - Department of Pediatrics Section of Adolescent.
Copyright Alcohol Medical Scholars Program1 The Relationships Between Alcohol Use Disorders and Nicotine Dependence Margaret Rukstalis, M.D. University.
Target: Tobacco Family Health Dec. 9, 2013 Entry Task: What are 5 side effects from using tobacco products? h?v=u_8BerrJg0M.
Addiction Treatment Works! Through Collaboration and Problem Solving amongst all disciplines.
Quittin’ Time: Helping Employees Become Tobacco-free June 2005.
What we need to know about smoking & tobacco addiction.
Tobacco Prevention. What Kills the Most Americans Every Year? Rank them in order from 1-10 AIDS Suicide Alcohol Fires Secondhand Smoke Heroin Tobacco.
Fatima Chaudhry. Why this drug was developed According to the Centers for Disease Control and Prevention (CDC), an estimated 45 million adults in the.
Rene Maximiliano Gomez, MD Head, Allergy & Asthma Unit Hospital San Bernardo, Salta - Argentina.
Journal Club Sidharth Bagga MD. Cytisus laborium L. (Golden rain acacia)
Demonstration of a Process- Outcome Link for Smoking Cessation Melissa M. Farmer, PhD 1,2 Elizabeth M. Yano, PhD 1,2 Brian S. Mittman, PhD 1,2 Scott E.
TOBACCO PREVENTION AND CONTROL PROGRAM Mike Maples, Assistant Commissioner Mental Health and Substance Abuse Services.
Real-world effectiveness of nicotine replacement therapy in pregnancy Leonie S. Brose, PhD Andy McEwen, PhD & Robert West, PhD University College London.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
Public Health & Hospital Health Care System Rural Cessation Collaboration to Improve Health.
Effect of Depression on Smoking Cessation Outcomes Sonne SC 1, Nunes EV 2, Jiang H 2, Gan W 2, Tyson C 1, Reid MS 3 1 Medical University of South Carolina,
Cherokee Health Systems Encouraging Tobacco Cessation Through the Five A’s: Ask, Advise, Assess, Assist, Arrange Mary Clare Champion, Ph.D. Cherokee Health.
Treating Chronic Pain in Adolescents Amanda Bye, PsyD, Behavioral Medicine Specialist Collaborative Family Healthcare Association 15 th Annual Conference.
What Kills the Most Americans Every Year?  Rank them in order from 1-10  AIDS  Suicide  Alcohol  Fires  Secondhand Smoke  Heroin  Tobacco  Homicide.
CCTN September 6 th, Recent Scientific Publications from the Clinical Trials Network David Liu, M.D. (CTN-0029) Harold Perl, Ph.D. (CTN-0015) Paul.
TOBACCO USE & OLDER SMOKERS. OLDER SMOKERS In 2004, 3.7 million people aged 65 and older were smokers and 16% of all people aged 50 and older smoked;
Increasing Access to Pharmacotherapy Jonathan P. Winickoff, MD, MPH Associate Professor in Pediatrics Harvard Medical School April 26, 2013.
Nicotine dependence It’s in ICD 10! MRCPsych addiction psychiatry seminars March 2010.
The COMBINE Study: Design and Methodology Stephanie S. O’Malley, Ph.D. for The COMBINE Study Research Group JAMA Vol. 295, , 2006 (May 3 rd.
Prepared by: Dr. Mohammad Shaikhani University of Sulaimani College of Medicine. Dept of Medicine.
Clinical trial 2. Objective To evaluate efficacy and safety of varenicline for smoking cessation compared with sustained-release bupropion (bupropion.
 2009 Johns Hopkins Bloomberg School of Public Health; American Academy of Pediatrics Julius B. Richmond Center of Excellence Jonathan D. Klein, MD, MPH.
SMOKING in ADOLESCENTS with PSYCHIATRIC or ADDICTIVE DISORDERS.
Factors associated with health care providers’ practice of smoking cessation interventions in public health facilities in Kiambu County, Kenya Dr Judy.
Smoking Cessation Services in a Baltimore County Title X Family Planning Program CityMatCH Urban Maternal and Child Health Leadership Conference Albuquerque,
Efficacy of Combination First Line Agents for Smoking Cessation Sneha Baxi, Pharm.D. Pharmacy Practice Resident University of Illinois at Chicago.
-Tobacco is the leading preventable cause of disease, disability, and death in the United States (NIDA, 2012). -About 1 in every 5 deaths in the U.S. result.
1 Cost efficacy of smoking cessation interventions Robert West University College London Logroño, October
1 Access to and use of aids to smoking cessation in the UK Robert West University College London Austin, Texas February 2007.
Randomized Controlled CTN Trial of OROS-MPH + CBT in Adolescents with ADHD and Substance Use Disorders Paula Riggs, M.D., Theresa Winhusen, PhD., Jeff.
Tobacco Smoking Smokless tobacco. Smoking Why teens start smoking
Acute exercise effects on craving and withdrawal symptoms among women attempting to quit smoking using nicotine replacement therapy Dr. Therese Harper.
Addressing Tobacco Use in Mental Health Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester.
Addressing Tobacco Use in Medical Settings Pharmacotherapy Materials Prepared By: Center for a Tobacco-Free Finger Lakes University of Rochester School.
TEEN HEALTH ISSUES.  Adolescents (ages 10 to 19) and young adults (ages 20 to 24) make up 21 percent of the population of the United States.  The behavioral.
Tobacco CHAPTER – Facts About Tobacco Tobacco is a woody, shrub-like plant with large leaves. These leaves are harvested and prepared for smoking.
1 Effects on smoking cessation of a national strategy to maximise NRT usage: the UK experience Robert West University College London WCTOH July 2006 Washington.
1 Should behavioural support for smoking cessation address wider psychological problems? University College London October 2013 Robert West.
6 myths and facts about tobacco use disorder in people with mental health and substance use disorders Associate Professor.
Anita R. Webb, PhD JPS Family Medicine Residency
Smoking and smoking cessation in the real world
Why and How to Quit Smoking
Robert West University College London London March 2008
Get smoker to their baseline for their behavioral health condition and initiating abstinence from substances. Then assess whether, in the past year, was.
ABCs of Behavioral Support
Alcohol, Other Drugs, and Health: Current Evidence May-June, 2018
Tobacco Prevention.
Presentation transcript:

Safety and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Addiction Tony Nguyen, PGY2

Case  Peter Gibbons 18 y/o male presenting for college physical  Doing well with no complaints  No significant PMHx/PSHx  No medications  Immunizations are UTD

 Home: Parents, 2 younger siblings  Education: Starting college at Va Tech, plans on engineering/computer science degree  Activities: Working at father’s software company this summer for money  Drugs: Denies drugs/EtOH, but admits to 3 yr hx of smoking 1 ppd. Wants to quit before college.  SSS: Denies SI/HI, +SA (2 yr relationship, always uses protection), and feels safe at home.

His only question:  Does nicotine replacement therapy work, and how safe is it?

Smoking Fast Facts  Nearly 21% of U.S. adults (44.5 million people) are cigarette smokers.  Responsible for an estimated 438,000 deaths per year (1 in 5 deaths)  An estimated 38,000 of these deaths are the result of secondhand smoke exposure

Smoking Fast Facts  Cigarette smoking results in more than $167 billion in costs annually, based on lost productivity ($92.4 billion) and health care expenditures ($75.5 billion)  In 2003 the cigarette industry spent almost $15.2 billion on advertising and promotional expenses - $41 million per day.

More Smoking Fast Facts*  Kills more people than car accidents, alcohol, homicide, suicide, drugs, fires, and AIDS combined  Single most preventable cause of disease in the US  Largest single cause of premature death in developed world *W. Adelman

Teenage Smoking Fast Facts  Almost 22% of high school students in the United States are current cigarettes smokers.  Each day, an estimated 1,500 teens younger than 18 begin smoking on a daily basis.

 86.8% of students who smoke nicotine at least once daily are chemically dependent under DSM IV mental health standards  Journal of Pediatric Psychology June, 2005 Journal of Pediatric Psychology June, 2005

Smoking cessation studies  1998: Prev Med: 1,210 established smokers in 6,427 polled 67% wanted to quit 60% of those attempted to quit 3% achieved cessation beyond 12 months

Studies  2001: Massachusetts: School nurse intervention Study between 71 HS showed that those with nurse intervention had 8x greater odds at quitting at 6 weeks and 6x greater at 12 weeks

Studies  Hypnosis Int J Clin Exp Hypn Jul 2006  Scott and White Memorial Hospital study  8 visits over 2 months of hypnotherapy  40% cessation after end of study and out to 26 weeks

Studies  Korea: Acupuncture! 159 HS students treated with “anti-smoking” acu- points on the ear for 4 weeks Control group – 79 students treated at other sites on the ear Result: 1 case of success (0.6%) in case group, zero in control group

Studies  Bupropion plus Nicotine patch Journal of Consulting and Clinical Psych 2004 Abstinence rates at weeks 10 and 26:  Patch + Bupropion: 23 % and 8%  Patch + Placebo: 28% and 7% Bupropion not effective But study found that large majority of teens in both groups reduced consumption and maintained the reduction over time with the nicotine replacement

Studies  J. Addiction 2005 – JW May et al… 30% of those attempting NRT had quit 39% of those NOT attempting NRT had quit

Back to the original question…  Is Nicotine replacement safe and efficacious for teens?

Safety and Efficacy of the Nicotine Patch and Gum for the Treatment of Adolescent Tobacco Addiction  Participants  Methods  Results  Conclusions

Participants  Inner city Baltimore  Outreach and recruitment over 4 year via media, schools, and churches  Eligibility based on history, physical exam, and laboratory screening

Participants  Inclusion Criteria: General good health Ages 13 to 17 Smoked ≥ 10 CPD for ≥ 6 months Minimal score 5 of Fagerstrom Test of Nicotine Dependence (FTND) Highly motivated to stop smoking

Participants  Exclusion Criteria Pregnancy and lactation (or those wanting to conceive) Chronic skin conditions Use of other tobacco products Use of tobacco cessation product w/in last 30 days Other drug or alcohol dependence Mania, psychosis, or acute depression  Those taking pyschotropic meds were not an excluded

Participant Stats  Avg age: 15  72.5% white  70% female  Avg of 18.8 Cigarettes/Day  FTND of 7

Fagerstr Ö m Test of Nicotine Dependence

 Dependence Level 0-2 Very low dependence 3-4 Low dependence 5 Medium dependence 6-7 High dependence 8-10 Very High dependence

Methods  Initial visits Fagerstr Ö m Questionnaire Expired CO level obtained Baseline nicotine and thiocyanate levels drawn via blood and saliva Pregnancy test for all females  Target quit date 1 week after visits

Methods  12 week study with weekly follow-ups  At each visit Exhaled CO measured Saliva levels of cotinine and thiocyanate obtained Used and unused patches collected, new ones dispensed  6 month post study follow up

Methods  Double blinded, randomized study  Three arms Nicotine Patch with placebo gum Nicotine Gum with placebo patch Placebo Patch and placebo Gum  All received Cognitive & behavior group therapy

Attrition  Patch 52.9% completed study  Gum 41.3%  Placebo 40%

Overall Results  Patch was significantly more effective than placebo with prolonged abstinence.  Level of expired CO and saliva levels unchanged. Possibly from compensatory smoking (deeper inhalation)?  Change in cigarettes per day decreased by an average of 80% across all three arms

Safety  Found to be safe 745 reported side effects Most common side effects: pruritis (130), erythema (111), headache (86) and fatigue (67)  Side effects comparable to adult trials  Felt by authors to not have affected retention in study

Results: Efficacy  Abstinence rates at 3 months: Patch: (17.7%) Gum: (6.5%) Placebo: (2.5%)

Abstinence over time

Are the results valid? Double blind Randomized All participants accounted for with completed follow up

Conclusions  Nicotine patch therapy combined with cognitive-behavioral intervention was safe and effective when compared to placebo for treatment

Study limitations  Small sample size; only 120 enrolled from 1347 who were originally interested Inclusion criteria may have been too strict  Resulted in a study with no sociodemographic difference 70 % white 70% female

Study limitations  Psychiatric comorbidities may have contributed to high drop out rate 75% had at least 1 psychiatric Dx (64% patch, 75% gum, and 85% placebo)  Oppositional Defiant Disorder (40%)  Conduct Disorder (15%)  ADHD (7%) ~25% taking psychotropic medications

Limitations  “Teens might have reported their cigarette consumption inaccurately…”  High drop out rate from gum arm not from adverse effects but rather taste

How does this effect our practice?  All studies show that the success rate of smoking cessation by any means (Patch, gum, Bupropion) remains poor  Studies with the best results show that the medicinal treatment was accompanied by behavioral intervention as done in this study Confirmed by reduction of 80% CPD in all three arms Swiss study showed reduction of 5 CPD had high chance of abstinence 3 years out

 Best way to stop smoking is prevention from smoking

PCM interventions  5 A’s Ask Advise Assess Assist Arrange

Advise  Bad breath, stinky clothes  Implications on health in long term  Money spent that could be used to buy other things 

Assess  Willingness to quit?  Have any attempts been made lately?  What has been attempted in past?

Assist  Help set a quit date  Help set up supportive environment of family and friends  Provide anticipation of side effects

Arrange  Arrange follow ups  Positive reinforcement

For best results…  Primary prevention  School/Office interventions  Behavior/group therapy  Patience  Persistence